The cardiac risk nobody mentions at diagnosis When a gynaecologist confirms PCOS, the conversation almost always centres on ...

The FDA cleared EchoNext, the first artificial intelligence tool to detect structural heart disease before symptoms present.

As heart disease is increasingly recognised in younger women, incorporating menstrual history into cardiovascular assessment ...

In the U.S., Hispanic/Latino populations are disproportionately at risk for eye diseases like glaucoma and diabetic ...

In patients with T2D and CKD, finerenone lowers the risk for adverse cardiovascular and kidney events compared with placebo, ...

For years, Body Mass Index (BMI) has been the standard tool for assessing health risks related to weight. However, growing ...

Elizabeth Cooney became STAT’s cardiovascular reporter in April with one fundamental question in mind: Why do we have so much cardiovascular and metabolic disease, and how can we do better? Liz covers ...

Liz covers cardiovascular and metabolic disease, asking why we’re not doing better or even losing ground against the world’s leading killer. Send tips on Signal at LizC.22. Where do we stand on ...

A peptide vaccine targeting PCSK9 has demonstrated sustained antibody responses and reductions in LDL cholesterol and atherosclerotic plaque formation in animal models, offering a potential long-term ...

Risk factors for cardiovascular disease have been formally identified for over six decades.

Cardiovascular disease remains the leading cause of death globally. To address this burden on health-care systems around the world, an in-depth understanding is needed about the incidence and ...